WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 555923
Description: QQN52061 is GPR34 receptor modulator, which can control function of GPR34 receptor (as antagonist or inverse agonist). QQN52061 was first reported in PCT Int. Appl. (2006), WO 2006088246. This product has not formal name. For the convenience of scientific communication, we named it by combining its Inchi key (3 letters from the first letter of each section) with the last 5 digit of its CAS#) according to MedKoo Chemical Nomenclature (https://www.medkoo.com/page/naming).
MedKoo Cat#: 555923
Chemical Formula: C31H26ClNO4
Exact Mass: 511.155
Molecular Weight: 512.002
Elemental Analysis: C, 72.72; H, 5.12; Cl, 6.92; N, 2.74; O, 12.50
Synonym: QQN52061; QQN-52061; QQN 52061;
IUPAC/Chemical Name: N-[(2E)-3-(4'-Chloro[1,1'-biphenyl]-4-yl)-1-oxo-2-propen-1-yl]-O-(phenylmethyl)tyrosine
InChi Key: QPRREELAPZFVLQ-WDOJQBHRSA-N
InChi Code: InChI=1S/C31H26ClNO4/c32-27-15-13-26(14-16-27)25-11-6-22(7-12-25)10-19-30(34)33-29(31(35)36)20-23-8-17-28(18-9-23)37-21-24-4-2-1-3-5-24/h1-19,29H,20-21H2,(H,33,34)(H,35,36)/b19-10+/t29-/m0/s1
SMILES Code: O=C(O)[C@H](CC1=CC=C(OCC2=CC=CC=C2)C=C1)NC(/C=C/C3=CC=C(C4=CC=C(Cl)C=C4)C=C3)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: to be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 512.002 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
Preparation of N-acyl-amino acid derivatives for controlling function of GPR34 receptor as antagonists or inverse agonists
Quick View Other Sources
By Ito, Fumio; Kimura, Eiji; Imai, Tomomi; Mori, Masaaki; Aramaki, Yoshio; Kohara, Yasuhisa; Sugo, Tsukasa; Hayase, Yoji; Kobayashi, Hiromi; Ogi, Kazuhiro
From PCT Int. Appl. (2006), WO 2006088246 A1 20060824. | Language: Japanese, Database: CAPLUS